Analysis of Clinical Effect of PD-1 Inhibitor Combined with Chemotherapy in the Treatment of Nasal Type NK/T Cell Lymphoma

被引：0
|
作者：
Fu, Juan [1 ]
Yin, Xianbao [2 ]
Ma, Qin [3 ]
机构：
[1] Zaozhuang Municipal Hosp, Dept Hematol, Zaozhuang, Peoples R China
[2] Zaozhuang Hosp Tradit Chinese Med, Dept Otorhinolaryngol, Zaozhuang, Peoples R China
[3] Zaozhuang Municipal Hosp, Dept Otorhinolaryngol, 41 Longtou Rd, Zaozhuang 277100, Shandong, Peoples R China
来源：
PANMINERVA MEDICA | 2021年
关键词：
PD-1; inhibitor; chemotherapy; clinical effect;
D O I：
10.23736/S0031-0808.20.04252-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：7
相关论文
共 50 条
  • [31] Extra nodal NK/T-cell lymphoma nasal type that responded to DeVIC combination chemotherapy
    Nomura, E
    Isoda, K
    Yamanaka, K
    Yamaguchi, M
    Hakamada, A
    Mizutani, H
    JOURNAL OF DERMATOLOGY, 2005, 32 (03): : 204 - 209
  • [32] NK/T-CELL LYMPHOMA, NASAL TYPE SUCCESSFULLY TREATED WITH PBRT AND CONCURRENT SMILE CHEMOTHERAPY
    Moreno, Paulina Roman
    Torrado, Andrea
    Arndt, Carola
    Mahajan, Anita
    Garrity, James
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [33] Intravascular large NK/T-cell lymphoma: a variant of extranodal NK/T-cell lymphoma, nasal type?
    Wenzhong Yu
    Ping Wang
    Hong Shen
    European Journal of Dermatology, 2019, 29 : 440 - 442
  • [34] Intravascular large NK/T-cell lymphoma: a variant of extranodal NK/T-cell lymphoma, nasal type?
    Yu, Wenzhong
    Wang, Ping
    Shen, Hong
    EUROPEAN JOURNAL OF DERMATOLOGY, 2019, 29 (04) : 440 - 442
  • [35] Clinical significance of cyclooxygenase-2 in NK/T-cell lymphoma, nasal type
    Shim, S
    Yang, W
    Koom, W
    Kim, Y
    Cho, J
    Suh, C
    You, S
    Kim, G
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S424 - S425
  • [36] L-asparaginase in the treatment of relapsing Nasal/Nasal type NK-T-cell lymphoma.
    Jaccard, A
    Suarez, F
    Zini, JM
    Turlure, P
    Trimoreau, F
    Petit, B
    Bordessoule, D
    Hermine, O
    BLOOD, 2004, 104 (11) : 233B - 233B
  • [37] Retrospective analysis of treatment outcomes for extranodal NK/T-cell lymphoma (ENKL), nasal type, stage I-IIE: single institute experience of combined modality treatment for early localized nasal extranodal NK/T-cell lymphoma (ENKL)
    Lee, Jayoung
    Cho, Seok-Goo
    Chung, Su-Mi
    Ryu, Mi Ryeong
    Kim, Sung Hwan
    Jang, Hong-Seok
    Choi, Byung-Ock
    ANNALS OF HEMATOLOGY, 2013, 92 (03) : 333 - 343
  • [38] Retrospective analysis of treatment outcomes for extranodal NK/T-cell lymphoma (ENKL), nasal type, stage I-IIE: single institute experience of combined modality treatment for early localized nasal extranodal NK/T-cell lymphoma (ENKL)
    Jayoung Lee
    Seok-Goo Cho
    Su-Mi Chung
    Mi Ryeong Ryu
    Sung Hwan Kim
    Hong-Seok Jang
    Byung-Ock Choi
    Annals of Hematology, 2013, 92 : 333 - 343
  • [39] PD-L1 inhibits the activity of T-cell in extranodal natural killer (NK)/T-cell lymphoma, nasal type
    Li, Pengfei
    Zhen, Zijun
    Wang, Zifeng
    Zhu, Jia
    Wan, Juan
    Lu, Suying
    Sun, Feifei
    Huang, Juntin
    Guo, Xiaofang
    Liao, Ru
    Liu, Quentin
    Sun, Xiaofei
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 : 36 - 37
  • [40] PD-1 Inhibitor Combined with Chemotherapy As a Salvage Therapy for Refractory DLBCL
    Li, Xin
    Zhang, Rui
    Li, Qing
    Mu, Juan
    Pu, Yedi
    Jiang, Yili
    Deng, Qi
    BLOOD, 2019, 134
12345